Hormonal and Metabolic Diseases

  • Vet Dominique HeripretEmail author
  • Hans S. Kooistra


Endocrine and metabolic disorders may result in changes in the skin and hair coat. With regard to thyroid disorders, hyperthyroidism is the most common endocrinopathy in cats, whereas hypothyroidism is rare in this species. Diabetes mellitus is also a common feline endocrinopathy. Disorders of the adrenal cortex associated with changes of the skin and hair coat also occur in cats and not only are confined to hypersecretion of cortisol but also include hypersecretion of sex steroids. In addition to the dermatological changes observed in these endocrine disorders, the dermatological changes associated with metabolic disorders, i.e. superficial necrolytic dermatitis, xanthomatosis and acquired cutaneous fragility syndrome, will be presented.


  1. 1.
    Diehm M, Dening R, Dziallas P, Wohlsein P, Schmicke M, Mischke R. Bilateral femoral capital physeal fractures in an adult cat with suspected congenital primary hypothyroidism. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2019;47:48–54.CrossRefGoogle Scholar
  2. 2.
    Jacobson T, Rochette J. Congenital feline hypothyroidism with partially erupted adult dentition in a 10-month-old male neutered domestic shorthair cat: a case report. J Vet Dent. 2018;35:178–86.CrossRefGoogle Scholar
  3. 3.
    Lim CK, Rosa CT, de Witt Y, Schoeman JP. Congenital hypothyroidism and concurrent renal insufficiency in a kitten. J S Afr Vet Assoc. 2014;85:1144.CrossRefGoogle Scholar
  4. 4.
    Gruffydd JBR, TJ J, Sparkes AH, Lucke VM. Preliminary studies on congenital hypothyroidism in a family of Abyssinian cats. Vet Rec. 1992;131:145–8.CrossRefGoogle Scholar
  5. 5.
    Bojanick K, Acke E, Jones BR. Congenital hypothyroidism of dogs and cats: a review. N Z Vet J. 2011;59:115–22.CrossRefGoogle Scholar
  6. 6.
    Crowe A. Congenital hypothyroidism in a cat. Can Vet J. 2004;45:168–70.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Schumm-Draeger PM, Länger F, Caspar G, Rippegather K, Hermann G, Fortmeyer HP, Usadel KH, Hübner K. Spontane Hashimoto-artige Thyreoiditis im Modell der Katze (Spontaneous Hashimoto-like thyroiditis in cats). Verh Dtsch Ges Pathol. 1996;80:297–301.PubMedGoogle Scholar
  8. 8.
    Peterson ME, Carothers MA, Gamble DA, Rishniw M. Spontaneous primary hypothyroidism in 7 adult cats. J Vet Intern Med. 2018;32:1864–73.CrossRefGoogle Scholar
  9. 9.
    Peterson ME, Nichols R, Rishnow M. Serum thyroxine and thyroid-stimulating hormone concentration in hyperthyroid cats that develop azotaemia after radioiodine therapy. J Small Anim Pract. 2017;58:519–30.CrossRefGoogle Scholar
  10. 10.
    Peterson ME. Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter. J Endocrinol. 2014;223:97–114.CrossRefGoogle Scholar
  11. 11.
    Thoday KL, Mooney CT. Historical, clinical and laboratory features of 126 hyperthyroid cats. Vet Rec. 1992;131:257–64.CrossRefGoogle Scholar
  12. 12.
    Boland LA, Barrs VR. Peculiarities of feline hyperadrenocorticism: update on diagnosis and treatment. J Feline Med Surg. 2017;19:933–47.CrossRefGoogle Scholar
  13. 13.
    Chiaramonte D, Greco DS. Feline adrenal disorders. Clin Tech Small Anim Pract. 2007;22:26–31.CrossRefGoogle Scholar
  14. 14.
    Valentin SY, Cortright CC, Nelson RW, et al. Clinical findings, diagnostic test results, and treatment outcome in cats with spontaneous hyperadrenocorticism: 30 cases. J Vet Intern Med. 2014;28:481–7.CrossRefGoogle Scholar
  15. 15.
    Daley CA, Zerbe CA, Schick RO, Powers RD. Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds. J Am Vet Med Assoc. 1993;202:956–60.PubMedGoogle Scholar
  16. 16.
    Peterson ME, Graves TK. Effects of low dosages of intravenous dexamethasone on serum cortisol concentrations in the normal cats. Res Vet Sci. 1988;44:38–40.CrossRefGoogle Scholar
  17. 17.
    Meij BP, Voorhout G, Van Den Ingh TS, Rijnberk A. Transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in 7 cats. Vet Surg. 2001;30:72–86.CrossRefGoogle Scholar
  18. 18.
    Mayer MN, Greco DS, LaRue SM. Outcomes of pituitary irradiation in cats. J Vet Intern Med. 2006;20:1151–4.CrossRefGoogle Scholar
  19. 19.
    Meij BP. Hypophysectomy as a treatment for canine and feline Cushing’s disease. Vet Clin North Am Small Anim Pract. 2001;31:1015–41.CrossRefGoogle Scholar
  20. 20.
    Meij B, Voorhout G, Rijnberk A. Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats. Mol Cell Endocrinol. 2002;197:89–96.CrossRefGoogle Scholar
  21. 21.
    Mellet-Keith AM, Bruyette D, Stanley S. Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004–2012). J Vet Intern Med. 2013;27:1471–7.CrossRefGoogle Scholar
  22. 22.
    Muschner AC, Varela FV, Hazuchova K, Niessen SJ, Pöppl ÁG. Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment. JFMS Open Rep. 2018;4:205511691876770. Scholar
  23. 23.
    Lien YH, Huang HP, Chang PH. Iatrogenic hyperadrenocorticism in 12 cats. J Am Anim Hosp Assoc. 2006;42:414–23.CrossRefGoogle Scholar
  24. 24.
    Middleton DJ, Watson ADJ, Howe CJ, Caterson ID. Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone. Can J Vet Res. 1987;51:60–5.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Selman PJ, Wolfswinkel J, Mol JA. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids. 1996;61:133–7.CrossRefGoogle Scholar
  26. 26.
    Boag AK, Neiger R, Church DB. Trilostane treatment of bilateral adrenal enlargement and excessive sex steroid hormone production in a cat. J Small Anim Pract. 2004;45:263–6.CrossRefGoogle Scholar
  27. 27.
    Boord M, Griffin C. Progesterone secreting adrenal mass in a cat with clinical signs of hyperadrenocorticism. J Am Vet Med Assoc. 1999;214:666–9.PubMedGoogle Scholar
  28. 28.
    Quante S, Sieber-Ruckstuhl N, Wilhelm S, Favrot C, Dennler M, Reusch C. Hyperprogesteronism due to bilateral adrenal carcinomas in a cat with diabetes mellitus. Schweiz Arch TierheilkdSchweiz Arch Tierheilkd. 2009;151:437–42.CrossRefGoogle Scholar
  29. 29.
    Rossmeisi JH, Scott-Montcrieff JC, Siems J, et al. Hyperadrenocorticism and hyperprogesteronemia in a cat with an adrenocortical adenocarcinoma. J Am Anim Hosp Assoc. 2000;36:512–7.CrossRefGoogle Scholar
  30. 30.
    Kimmel SE, Christiansen W, Byrne KP. Clinicopathological, ultrasonographic, and histopathological findings of superficial necrolytic dermatitis with hepatopathy in a cat. J Am Anim Hosp Assoc. 2003;39:23–7.CrossRefGoogle Scholar
  31. 31.
    Asakawa MG, Cullen JM, Linder KE. Necrolytic migratory erythema associated with a glucagon-producing primary hepatic neuroendocrine carcinoma in a cat. Vet Dermatol. 2013;24:466–9.CrossRefGoogle Scholar
  32. 32.
    Grieshaber TL. Spontaneous cutaneous (eruptive) xanthomatosis in two cats. J Am Anim Hosp Assoc. 1991;27:509.Google Scholar
  33. 33.
    Ravens PA, Vogelnest LJ, Piripi SA. Unique presentation of normolipæmic cutaneous xanthoma in a cat. Aust Vet J. 2013;91:460–3.CrossRefGoogle Scholar
  34. 34.
    McKnight CN, Lewis LJ, Gamble DA. Management and closure of multiple large cutaneous lesions in a juvenile cat with severe acquired skin fragility syndrome secondary to iatrogenic hyperadrenocorticism. J Am Vet Med Assoc. 2018;252:210–4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.CHV FregisArcueilFrance
  2. 2.CHV PommeryReimsFrance
  3. 3.Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht UniversityUtrechtThe Netherlands

Personalised recommendations